Published in Ann Rheum Dis on September 01, 2006
Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum (2009) 2.32
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum (2009) 2.26
Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control (2008) 1.93
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum (2008) 1.71
The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol (2008) 1.25
Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc (2007) 0.99
Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus. Clin Exp Immunol (2009) 0.97
Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: a pilot study. Lupus (2011) 0.94
Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort. Arthritis Care Res (Hoboken) (2013) 0.89
Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus. PLoS One (2013) 0.88
Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis (2006) 0.87
Association of systemic lupus erythematosus clinical features with European population genetic substructure. PLoS One (2011) 0.85
Disruptions in energy balance: does nature overcome nurture? Physiol Behav (2007) 0.83
Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort. Arthritis Rheum (2008) 0.83
A study of racial/ethnic differences in treatment preferences among lupus patients. Rheumatology (Oxford) (2012) 0.82
Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary. Rheumatology (Oxford) (2015) 0.80
Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus. Ann Rheum Dis (2007) 0.79
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort. Semin Arthritis Rheum (2011) 0.78
Clinical expression and course in patients with late onset systemic lupus erythematosus. Hippokratia (2013) 0.77
The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol (2016) 0.77
Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. Lupus (2010) 0.77
Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study. Lupus Sci Med (2016) 0.75
Creating musculoskeletal programs for culturally diverse, underserved communities: a community-based participatory research survey. HSS J (2014) 0.75
Social Support and Self-Reported Stress Levels in a Predominantly African American Sample of Women with Systemic Lupus Erythematosus. Autoimmune Dis (2015) 0.75
Development and validation of a simple lupus severity index using ACR criteria for classification of SLE. Lupus Sci Med (2016) 0.75
Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study. Lupus Sci Med (2015) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Ethnic-affiliation estimation by use of population-specific DNA markers. Am J Hum Genet (1997) 6.72
Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet (2000) 6.13
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02
Describing race, ethnicity, and culture in medical research. BMJ (1996) 3.99
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
Sociocultural issues in clinical research. Arthritis Rheum (2001) 2.71
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum (2001) 2.68
Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 2.68
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum (2001) 2.13
Outcomes of self-help education for patients with arthritis. Arthritis Rheum (1985) 1.95
The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Baltimore) (2004) 1.89
Neighbourhood environments and mortality in an elderly cohort: results from the cardiovascular health study. J Epidemiol Community Health (2004) 1.75
Population data on the thirteen CODIS core short tandem repeat loci in African Americans, U.S. Caucasians, Hispanics, Bahamians, Jamaicans, and Trinidadians. J Forensic Sci (1999) 1.70
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum (2004) 1.69
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum (1998) 1.58
The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index. J Rheumatol (1985) 1.55
The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 1.55
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis (2003) 1.38
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. Rheumatology (Oxford) (2003) 1.36
Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis (1982) 1.35
Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum (2004) 1.35
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum (1998) 1.35
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum (2004) 1.21
Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) (2003) 1.19
Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. J Rheumatol (2005) 1.17
Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol (2003) 1.17
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol (2003) 1.14
Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study. Rheumatology (Oxford) (2004) 1.13
SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J Rheumatol (1998) 1.13
Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol (2000) 1.12
Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus (2004) 1.11
Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol (2002) 1.11
Dimensions of illness behaviour as measured by the Illness Behaviour Questionnaire: a replication study. J Psychosom Res (1993) 1.09
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity (2005) 1.03
An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) (2001) 1.02
Do lupus disease activity measures detect clinically important change? J Rheumatol (2000) 1.02
Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus (1997) 1.01
Systemic lupus erythematosus in three ethnic groups. XVIII. Factors predictive of poor compliance with study visits. Arthritis Rheum (2004) 1.00
Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus (2004) 0.99
Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation. Ann Rheum Dis (1992) 0.95
Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores. Arthritis Rheum (2002) 0.92
Efficacy of psychoeducational interventions on pain, depression, and disability in people with arthritis: a meta-analysis. J Rheumatol Suppl (1987) 0.91
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus. Ann Behav Med (2002) 0.90
DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. J Autoimmun (1999) 0.89
Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI). Lupus (2005) 0.89
Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM). Joint Bone Spine (2003) 0.88
Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus (1994) 0.84
Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group. Rheumatol Int (1998) 0.84
Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol (1995) 0.83
Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol (2001) 0.83
Measuring disease activity in systemic lupus: progress and problems. J Rheumatol (2002) 0.78
The effectiveness and efficiency of health promotion in specialty clinic care. Med Care (1995) 0.77
Visual processing impairment and risk of motor vehicle crash among older adults. JAMA (1998) 4.49
Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol (2001) 3.87
Sociocultural issues in clinical research. Arthritis Rheum (2001) 2.71
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum (2001) 2.68
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther (2007) 2.54
Longitudinal study of elbow and shoulder pain in youth baseball pitchers. Med Sci Sports Exerc (2001) 2.43
Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol (2000) 2.39
A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum (2007) 2.24
Long-term outcome of patients with asystole induced by head-up tilt test. Eur Heart J (2002) 2.21
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum (2001) 2.13
Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly. Ophthalmic Epidemiol (1998) 2.07
Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus (2002) 2.03
Prognosis in ischemic heart disease. Can you tell as much at the bedside as in the nuclear laboratory? Arch Intern Med (1992) 2.03
[Current status of clinical nutrition at the network of public hospitals from Castilla y León]. Nutr Hosp (2006) 2.02
Vision impairment and driving. Surv Ophthalmol (1999) 1.95
Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest (2000) 1.94
Postprandial hypotension in 499 elderly persons in a long-term health care facility. J Am Geriatr Soc (1994) 1.92
Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis Rheum (1988) 1.91
Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum (2001) 1.87
Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope) Ann Intern Med (1995) 1.86
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus (2002) 1.85
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis (2013) 1.81
Visual and medical risk factors for motor vehicle collision involvement among older drivers. Br J Ophthalmol (2008) 1.79
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum (2004) 1.75
Association of hostility with coronary artery calcification in young adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. JAMA (2000) 1.74
Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet (1986) 1.74
Molecular analysis of the lactacin F operon. Appl Environ Microbiol (1993) 1.74
Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol (2001) 1.72
Relation of risk factor levels in young adulthood to parental history of disease. The CARDIA study. Circulation (1991) 1.71
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain (2009) 1.69
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis (2007) 1.69
Factors related to driving difficulty and habits in older drivers. Accid Anal Prev (2001) 1.67
Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am (1992) 1.66
Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum (2005) 1.64
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) (2007) 1.63
Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol (1998) 1.63
Visual risk factors for crash involvement in older drivers with cataract. Arch Ophthalmol (2001) 1.62
Aging and dark adaptation. Vision Res (1999) 1.62
Two subsets of epithelial cells in the thymic medulla. J Exp Med (1992) 1.59
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum (1998) 1.58
A molecular analysis of the low serum deoxyribonuclease activity in lupus patients. Arthritis Rheum (2001) 1.57
Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology (1996) 1.54
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum (1996) 1.54
Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet (2009) 1.53
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun (2008) 1.53
Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol (1993) 1.52
Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum (1996) 1.51
The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS (1996) 1.51
Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum (2007) 1.51
Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon (2010) 1.50
Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients. Cancer (1994) 1.50
Allergic reaction caused by local anesthetic agents belonging to the amide group. J Allergy Clin Immunol (1997) 1.49
Health-related quality of life and visual and cognitive impairment among nursing-home residents. Br J Ophthalmol (2008) 1.47
Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J (2001) 1.47
The penetration of sodium into the epithelium of the frog skin. J Gen Physiol (1970) 1.44
[Association of nocturnal penile rigidity with testosterone, metabolic syndrome, and other variables: a prospective cross-sectional pilot study]. Actas Urol Esp (2011) 1.43
Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis. J Neuroimmunol (2010) 1.40
Biogenic amines in fermented foods. Eur J Clin Nutr (2010) 1.40
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum (1996) 1.39
Organ heavy-metal accumulation during parenteral nutrition is associated with pathologic abnormalities in rats. Nutrition (2001) 1.39
Paired-data analysis is required in the study by May et al. Endoscopy (2012) 1.39
Evaluation of renal tubular functions in convalescent phase of hemorrhagic fever with renal syndrome. Am J Nephrol (1998) 1.39
A pilot study of intracavitary hyperthermia combined with radiation in the treatment of oesophageal carcinoma. Int J Hyperthermia (1998) 1.39
Depressive symptoms and mortality in elderly persons. J Gerontol (1992) 1.37
Geographic variation and environmental risk factors for the incidence of initial kidney stones in patients with spinal cord injury. J Urol (2000) 1.36
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. Rheumatology (Oxford) (2003) 1.36
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum (2001) 1.36
Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol (1994) 1.35
Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med (1995) 1.35
Timed instrumental activities of daily living tasks: relationship to visual function in older adults. Optom Vis Sci (2001) 1.35
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum (1998) 1.35
Cerebral salt wasting syndrome: review. Eur J Intern Med (2008) 1.35
Surgery for pulmonary aspergillosis. J Thorac Cardiovasc Surg (1969) 1.34
Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron (1995) 1.31